Home Cart Sign in  
Chemical Structure| 671-16-9 Chemical Structure| 671-16-9

Structure of Procarbazine
CAS No.: 671-16-9

Chemical Structure| 671-16-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Procarbazine is a chemotherapy medication used for the treatment of Hodgkin's lymphoma and brain cancers.

Synonyms: Procarbazine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Ingraham, Charles H. IV ; Stalinska, Joanna ; Carson, Sean C. ; Colley, Susan B. ; Rak, Monika ; Lassak, Adam , et al.

Abstract: Glioblastomas are highly aggressive brain tumors for which therapeutic options are very limited. In a quest for new anti-glioblastoma drugs, we focused on specific structural modifications to the benzoyl-phenoxy-acetamide (BPA) structure present in a common lipid-lowering drug, fenofibrate, and in our first prototype glioblastoma drug, PP1. Here, we propose extensive computational analyses to improve the selection of the most effective glioblastoma drug candidates. Initially, over 100 structural BPA variations were analyzed and their physicochemical properties, such as water solubility (- logS), calculated partition coefficient (ClogP), probability for BBB crossing (BBB_SCORE), probability for CNS penetration (CNS-MPO) and calculated cardiotoxicity (hERG), were evaluated. This integrated approach allowed us to select pyridine variants of BPA that show improved BBB penetration, water solubility, and low cardiotoxicity. Herein the top 24 compounds were synthesized and analyzed in cell culture. Six of them demonstrated glioblastoma toxicity with IC50 ranging from 0.59 to 3.24 µM. Importantly, one of the compounds, HR68, accumulated in the brain tumor tissue at 3.7 ± 0.5 µM, which exceeds its glioblastoma IC50 (1.17 µM) by over threefold.

Alternative Products

Product Details of Procarbazine

CAS No. :671-16-9
Formula : C12H19N3O
M.W : 221.30
SMILES Code : O=C(NC(C)C)C1=CC=C(CNNC)C=C1
Synonyms :
Procarbazine
MDL No. :MFCD00866411

Safety of Procarbazine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335-H351-H361
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Procarbazine

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00431561 Glioblastoma ... More >>Anaplastic Astrocytoma Less << Phase 2 Completed - Austria ... More >> Universitätsklinik Innsbruck; Abteilung für Neurochirurgie Innsbruck, Austria, 6020 Landes-Nervenklinik Wagner-Jauregg Linz, Austria, 4020 Kaiser Franz Josef Spital, Abteilung für Neurologie Wien, Austria, 1100 Georgia Sarajishvili Institute of Clinical Neurology and Neurosurgery Tbilisi, Georgia, 0114 Germany Medizinische Klinik und Poliklinik mit Schwerpunkt Onkologie und Hämatologie, Charité Campus Mitte Berlin, Germany, 10117 Klinik und Poliklinik für Neurologie Cottbus, Germany, 03048 Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Dresden, Germany, 01307 Universitätsklinikum Gießen, Neurochirurgische Universitätsklinik Gießen, Germany, 35392 Universitätsklinikum Kiel, Klinik für Neurochirurgie Kiel, Germany, 24106 Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie Leipzig, Germany, 04103 Universitätsklinik Magdeburg, Klinik für Neurochirurgie Magdeburg, Germany, 39120 Universitätskliniken Mainz, Neurochirurgische Klinik und Poliklinik Mainz, Germany, 55131 Universitätsklinikum Münster, Klinik und Poliklinik für Neurochirurgie Münster, Germany, 48149 Klinikum und Poliklinik für Neurologie, Universität Regensburg Regensburg, Germany, 93053 Klinikum Saarbrücken, Neurochirurgie Saarbrücken, Germany, 66119 Neurologische Universitätsklinik Tübingen Tübingen, Germany, 72076 India Department of Neurosurgery, Amrita Institute of Medical Sciences & Research Centre Cochin, Kerala, India, 682026 Sree Chitra Tirunal Institute for Medical Sciences & Technology, Department of Neurosurgery Trivandrum, Kerala, India, 695011 Manipal Hospital; Manipal Institute for Neurological Disorders Bangalore, India, 560017 Department of Neurosurgery, National Institute of Mental Health and Neurosciences Bangalore, India, 560029 Department of Medical Oncology, Nizam's Institute of Medical Sciences Hyderabad, India, 500082 Department of Neurosurgery, LTMG Hospital & LTM Medical College Mumbai, India, 400022 Department of Neurosurgery, Neurosciences Center New Dehli, India, 110029 Department of Neurological Sciences, Christian Medical College & Hospital Vellore, India, 632004 Israel Soroka Medical Center, Neurosurgery Department Beer Sheva, Israel Rambam Medical Center, Neurosurgery Department Haifa, Israel, 31096 Rabin Medical Center, Neurosurgery Department Petach Tikva, Israel, 49100 Russian Federation Sverdlovsk Regional Oncological Clinic Ekaterinburg, Russian Federation, 620036 Republican Clinical Hospital of Ministry of Health of Tatarstan Republic Kazan, Russian Federation, 420064 Burdenko Neurosurgery Research Institute Moscow, Russian Federation, 125047 Omsk State Medical Academy; State Educational Institution of Higher Professional Education Omsk, Russian Federation, 644099 State Institution of Healthcare, Samara Regional Clinical Hospital in the name of M.I. Kalinin Samara, Russian Federation, 443095 Polenov Neurosurgery Research Institute St. Petersburg, Russian Federation, 191104 Military Medical Academy named after I.S.M. Kirov, Neurosurgery Department St. Petersburg, Russian Federation, 194175 Medical Center "XXI century" St. Petersburg, Russian Federation, 194354 Tcheliabinsk Regional Clinical Hospital; State Medical Institution for Prophylaxis and Treatment Tcheliabinsk, Russian Federation, 454076 Less <<
NCT00592111 Pediatric Hod... More >>gkin's Disease Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00025064 Lymphoma Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Meyerstein Institute of Oncology at University College of London Hospitals London, England, United Kingdom, WIT 3AA Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00049595 Lymphoma Phase 3 Active, not recruiting - -
NCT00003421 Lymphoma Phase 3 Completed - United Kingdom ... More >> St. James's Hospital Leeds, England, United Kingdom, LS9 7TF Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Less <<
NCT00416377 Lymphoma Not Applicable Unknown - -
NCT00002462 Lymphoma Phase 3 Active, not recruiting - -
NCT00416832 Lymphoma Phase 2 Completed - -
NCT00379041 Lymphoma Phase 3 Active, not recruiting - -
NCT00574496 Lymphoma Phase 2 Active, not recruiting November 2019 United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00822120 Lymphoma Nonn... More >>eoplastic Condition Less << Phase 2 Active, not recruiting April 2020 -
NCT00265031 Hodgkin′s Lymphoma Phase 3 Completed - -
NCT00264953 Hodgkin′s Lymphoma Phase 3 Completed - -
NCT00822120 - Active, not recruiting - -
NCT01132807 Lymphoma Phase 2 Completed - -
NCT00003101 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Illinois Evanston Northwestern Health Care Evanston, Illinois, United States, 60201 Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Canada, Alberta Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Less <<
NCT00003788 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - United States, Colorado ... More >> Rocky Mountain Neurological Associates Englewood, Colorado, United States, 80110 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, Pennsylvania Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 Canada, Ontario St. Michael's Hospital-Annex Toronto, Ontario, Canada, M5B 1A6 Less <<
NCT00187057 Ataxia-Telangiectasia Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00433433 Lymphoma Phase 3 Completed - Netherlands ... More >> Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Less <<
NCT01764230 Hodgkin Lymphoma ... More >> Hodgkin Disease Less << Not Applicable Completed - Czech Republic ... More >> Brno University Hospital and Masaryk University School of Medicine Brno, Czech Republic, 62500 Less <<
NCT01304849 Hodgkin's Lymphoma Not Applicable Completed - India ... More >> Department of Medical Oncology, Cancer Institute (WIA), Adyar Chennai, Tamil Nadu, India, 600020 Less <<
NCT00003113 Lymphoma Phase 2 Terminated - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00678327 Lymphoma Phase 3 Active, not recruiting December 2018 United Kingdom ... More >> Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Less <<
NCT01356680 Hodgkin Lymphoma Phase 3 Active, not recruiting December 2019 Germany ... More >> 1st Dept. of Medicine, Cologne University Hospital Cologne, Germany Less <<
NCT03632135 Recurrent Glioblastoma Phase 3 Recruiting January 31, 2022 United States, Mississippi ... More >> University of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 Contact: Mark D. Anderson, MD    601-984-5517    manderson4@umc.edu    United States, Ohio University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Nicholas Marko, MD    513-558-3559    nicholas.marko@uc.edu    Contact: , RN          Toledo University Recruiting Toledo, Ohio, United States, 43614 Contact: Jason Schroeder, MD    419-383-4000    Jason.Schroeder5@UToledo.edu    Contact: Stephanie Smiddy, RN    419-383-6962    stephanie.smiddy@UToledo.edu    United States, Pennsylvania The Penn State Univeristy College of Medicine Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Dawit Aregawi, MD    717-531-3828    daregawi@PennStateHealth.psu.edu    Allegheny Health Network Recruiting Pittsburgh, Pennsylvania, United States, 15212 Contact: Tulika Ranjan, MD    412-770-3039    Tulika.RANJAN@ahn.org    United States, West Virginia Charleston Area Medical Center Recruiting Charleston, West Virginia, United States, 25326 Contact: Steven Jubelirer, MD    304-388-8380    steven.jubelirer@camc.org    Contact: Tina Garten, RN    304-388-9995    Tina.Garten@camc.org Less <<
NCT00088400 Glioblastoma Phase 3 Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT02661503 Classical Hodgkin Lymphoma Phase 3 Recruiting September 2025 Germany ... More >> University Hospital of Cologne Recruiting Cologne, Germany Contact: Peter Borchmann, Prof. Less <<
NCT00704080 Mixed Gliomas ... More >> Malignant Gliomas Glioblastoma Multiforme Less << Phase 1 Completed - United States, Alabama ... More >> Investigational Site Number Birmingham, Alabama, United States, 35205 United States, California Investigational Site Number Los Angeles, California, United States, 90024 United States, Massachusetts Investigational Site Number Boston, Massachusetts, United States, 02115 United States, New York Investigational Site Number New York, New York, United States, 10021 Investigational Site Number Rochester, New York, United States, 14642 United States, Ohio Investigational Site Number Cleveland, Ohio, United States, 44195 Less <<
NCT00877747 - Unknown October 2015 Italy ... More >> Azienda Ospedaliera Santa Croce e Carle Cuneo, Italy, 12100 Less <<
NCT00667615 Hodgkin's Disease ... More >> Lymphoma Less << Phase 1 Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center @ BaskingRidge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Cornell Medical Center New York, New York, United States Memorial Sloan Kettering Cancer Center @ Phelps Sleepy Hollow, New York, United States, 10591 Less <<
NCT03582254 Primary Central Nervous System... More >> Lymphoma Less << Not Applicable Recruiting May 12, 2020 France ... More >> Pitié Salpêtrière Hospital Recruiting Paris, France, 75013 Contact: Aurélie KAS, Dr Less <<
NCT00667615 - Completed - -
NCT01358747 Hodgkin's Lymphoma Phase 3 Completed - -
NCT01130194 Follicular Lymphoma Phase 2 Completed - United States, Missouri ... More >> Saint Louis University Cancer Center Saint Louis, Missouri, United States, 63110 Less <<
NCT01390584 Lymphoma Phase 2 Terminated(slow accrual) - United States, California ... More >> Stanford Cancer Center Stanford, California, United States, 94305-5824 United States, Pennsylvania McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 Less <<
NCT01569204 Hodgkin Lymphoma Phase 2 Completed - Germany ... More >> 1st Dept. of Medicine, Cologne University Hospital Cologne, Germany Less <<
NCT00666484 Lymphoma Neur... More >>otoxicity Less << Phase 2 Completed - United Kingdom ... More >> Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF University College Hospital - London London, England, United Kingdom, NW1 2PG King's College Hospital London, England, United Kingdom, SE5 9RS Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Less <<
NCT00577993 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02298283 Hodgkin Lymphoma Phase 2 Recruiting February 2021 France ... More >> CH Victor Dupouy Recruiting Argenteuil, France, 95100 Contact: Driss CHAOUI, MD       driss.chaoui@ch-argenteuil.fr    Principal Investigator: Driss CHAOUI, MD          Polyclinique Bordeaux Nord Recruiting Bordeaux, France, 33300 Contact: Olivier FITOUSSI, MD       o.fitoussi@bordeauxnord.com    Contact: Olivier          Principal Investigator: FITOUSSI, MD          Centre François Baclesse Recruiting Caen, France, 14076 Contact: Christophe FRUCHART, MD       c.fruchart@baclesse.unicancer.fr    Principal Investigator: Christophe FRUCHART, MD          CH de Chambéry Recruiting Chambéry, France, 73011 Contact: Gian Mathéo PICA, MD       gian-matteo.pica@ch-chambery.fr    Principal Investigator: Gian Mathéo PICA, MD          CH Sud Francilien Recruiting Corbeil-Essonnes, France, 91108 Contact: Bertrand JOLY, MD       bertrand.joly@ch-sud-francilien.fr    Principal Investigator: Bertrand JOLY, MD          Hôpital Henri Mondor Recruiting Creteil, France, 94010 Contact: Corinne HAIOUN, Prof       corinne.haioun@hmn.aphp.fr    Principal Investigator: Corinne HAIOUN, Prof          CHU de Dijon - Hôpital le Bocage Recruiting Dijon, France, 21034 Contact: Olivier CASASNOVAS, MD       olivier.casasnovas@chu-dijon.fr    Principal Investigator: Olivier CASASNOVAS, MD          Hôpital André Mignot Recruiting Le Chesnay, France, 78157 Contact: Hassan FARHAT, MD       hfarhat@ch-versailles.fr    Principal Investigator: Hassan FARHAT, MD          Clinique Victor Hugo Recruiting Le Mans, France, 72000 Contact: Katell LE DÛ, MD       k.ledu@cjb72.org    Principal Investigator: Katell LE DÛ, MD          CHRU Lille - Hôpital Claude Huriez Recruiting Lille, France, 59037 Contact: Franck MORSCHHAUSER, Prof       franck.morschhauser@chru-lille.fr    Principal Investigator: Franck MORSCHHAUSER, Prof          CHU de Limoges Recruiting Limoges, France, 87042 Contact: Mohamed TOUATI, MD       mohamed.touati@chu-limoges.fr    Principal Investigator: Mohamed TOUATI, MD          Centre Léon Bérard Recruiting Lyon, France, 69008 Contact: Emmanuelle NICOLAS- VIRELIZIER, MD       emmanuelle.nicolas@lyon.unicancer.fr    Principal Investigator: Emmanuelle NICOLAS- VIRELIZIER, MD          Institut Paoli Calmette Recruiting Marseille, France, 13273 Contact: Réda BOUABDALLAH, MD       bouabdallahr@ipc.unicancer.fr    Principal Investigator: Réda BOUABDALLAH, MD          Hôpital de la Conception Recruiting Marseille, France, 13385 Contact: Régis COSTELLO, Prof       regis.costello@free.fr    Principal Investigator: Régis COSTELLO, Prof          CHU Montpellier - Saint ELOI Recruiting Montpellier, France, 34295 Contact: Philippe QUITTET, MD       p-quittet@chu-montpellier.fr    Principal Investigator: Philippe QUITTET, MD          CHU de Nantes Recruiting Nantes, France, 44093 Contact: Thomas GASTINNE, MD       thomas.gastinne@chu-nantes.fr    Principal Investigator: Thomas GASTINNE, MD          Hôpital Saint Louis Recruiting Paris cedex 10, France, 75475 Contact: Pauline BRICE, MD       pauline.brice@sls.aphp.fr    Principal Investigator: Pauline BRICE, MD          Hôpital Cochin Recruiting Paris, France, 75004 Contact: Bénédicte DEAU-FISCHER, MD       benedicte.deau-fischer@cch.aphp.fr    Principal Investigator: Bénédicte DEAU-FISCHER, MD          Hôpital de la Pitié Salpétrière Recruiting Paris, France, 75651 Contact: Jean GABARRE, MD       jean.gabarre@psl.aphp.fr    Principal Investigator: Jean GABARRE, MD          CH Perpignan Recruiting Perpignan, France, 66046 Contact: Laurence SANHES, MD       laurence.sanhes@ch-perpignan.fr    Principal Investigator: Laurence SANHES, MD          Hôpital Haut Lévêque Recruiting Pessac, France, 33604 Contact: Krimo BOUABDALLAH, MD       krimo.bouabdallah@chu-bordeaux.fr    Principal Investigator: Krimo BOUABDALLAH, MD          CHU Lyon Sud Recruiting Pierre Bénite Cedex, France, 69495 Contact: Gilles SALLES, Prof       gilles.salles@chu-lyon.fr    Principal Investigator: Gilles SALLES, Prof          CHU Robert Debre Recruiting Reims, France, 51092 Contact: Alain DELMER, MD       adelmer@chu-reims.fr    Principal Investigator: Alain DELMER, MD          CHU Pontchaillou Recruiting Rennes, France, 35033 Contact: Thierry LAMY de la CHAPELLE, Prof       thierry.lamy.de.la.chapelle@chu-rennes.fr    Principal Investigator: Thierry LAMY de la CHAPELLE, Prof          Centre Henri Becquerel Recruiting Rouen, France, 76000 Contact: Aspasia STAMATOULLAS, MD       aspasia.stamatoullas@chb.unicancer.fr    Principal Investigator: Aspasia STAMATOULLAS, MD          CHU de Strasbourg Recruiting Strasbourg, France, 67098 Contact: Luc-Matthieu FORNECKER, MD       luc-matthieu.fornecker@chru-strasbourg.fr    Principal Investigator: Luc-Matthieu FORNECKER, MD          I.U.C.T Oncopole Recruiting Toulouse, France, 31059 Contact: Cécile BOREL, MD       borel.c@chu-toulouse.fr    Principal Investigator: Cécile BOREL, MD          CHU Bretonneau Recruiting Tours, France, 37044 Contact: Marjan ERTAULT, MD       m.ertault@chu-tours.fr    Principal Investigator: Marjan ERTAULT, MD          CHU de Brabois Recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Serge BOLOGNA, MD       s.bologna@chu-nancy.fr    Principal Investigator: Serge BOLOGNA, MD          Gustave Roussy Cancer Campus Recruiting Villejuif, France, 94805 Contact: Vincent RIBRAG, MD       vincent.ribrag@gustaveroussy.fr    Principal Investigator: Vincent RIBRAG, MD Less <<
NCT01251107 Hodgkin Lymphoma Phase 3 Completed - Italy ... More >> Fondazione IRCCS Istituto Nazionale di Tumori di Milano Milano, Italy Less <<
NCT00433459 Lymphoma Phase 3 Completed - Germany ... More >> Universitaetsklinikum Giessen-Marburg Giessen, Germany, D-35385 United Kingdom Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Less <<
NCT00002944 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 3 Completed - -
NCT01118026 Lymphoma Phase 2 Active, not recruiting - -
NCT00717210 Anaplastic Astrocytoma ... More >> Oligodendroglioma Oligoastrocytoma Less << Phase 3 Completed - Germany ... More >> University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 Neurology and Radiotherapy Tübingen, Baden-Württemberg, Germany, 72076 Klinikum Aschaffenburg Aschaffenburg, Germany Nervenklinik Bamberg, Germany Charite Berlin, Germany Neurosurgery Düsseldorf, Germany Radiotherapy Erlangen, Germany Neurology Essen, Germany Neurosurgery Frankfurt, Germany Neurosurgery Kiel, Germany Neurosurgery Mainz, Germany County District Hospital Regensburg, Germany Less <<
NCT00003375 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Phase 3 Completed - -
NCT01468740 HIV-associated Hodgkin Lymphom... More >>a Less << Phase 2 Unknown July 2012 Germany ... More >> Vivantes Auguste Victoria Klinikum Recruiting Berlin, Germany, 12157 Contact: Markus Müller, MD    0049 30 130 20 2321    Markus.Mueller2@vivantes.de    Contact: Marcel Berger, MD    0049 30 130 20 2321    Marcel.Berger@vivantes.de    Sub-Investigator: Markus Müller, MD          Sub-Investigator: Marcel Berger, MD          Principal Investigator: Keikawus Arasteh, MD          Ärzteforum Seestrasse Recruiting Berlin, Germany, 13347 Contact: Jan Siehl, MD    0049 30 455095-0    jan.siehl@aerzteforum-seestrasse.de    Principal Investigator: Jan Siehl, MD          Universiy of Bonn Recruiting Bonn, Germany, 53127 Contact: Juergen Rockstroh, MD    0049 228 287 16558    Rockstroh@uni-bonn.de;    Principal Investigator: Jürgen Rockstroh, MD          University of Cologne Recruiting Cologne, Germany, 50924 Contact: Christoph Wyen, MD    0049 221 478 88835    christoph.wyen@uk-koeln.de    Contact: Gerd Fätkenheuer, MD    0049 221 478 4886    g.faetkenheuer@uni-koeln.de    Sub-Investigator: Christoph Wyen, MD          Principal Investigator: Gerd Fätkenheuer, MD          University of Frankfurt Recruiting Frankfurt, Germany, 60590 Contact: Timo Wolf, MD    0049 69 6301 5452    Timo.Wolf@kgu.de    Principal Investigator: Timo Wolf, MD          Asklepios Klinikum St. Georg Recruiting Hamburg, Germany, 20099 Contact: Maike Nickelsen, MD    0049 40 18 18 85 20 05    m.nickelsen@asklepios.com    Principal Investigator: Maike Nickelsen, MD          Infektionsmedizinisches Zentrum Hamburg Recruiting Hamburg, Germany, 20146 Contact: Christian Hoffmann, MD    0049 40 4132420    hoffmann@ich-hamburg.de;    Principal Investigator: Christian Hoffmann, MD          Harlaching Hospital Recruiting Munich, Germany, 81545 Contact: Marcus Hentrich, MD    0049 89 6210 2663 or 2731    marcus.hentrich@klinikum-muenchen.de    Principal Investigator: Marcus Hentrich, MD Less <<
NCT00734773 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Neurotoxicity Less << Early Phase 1 Withdrawn(Lack of funding) - -
NCT01652261 Hodgkin Lymphoma Phase 3 Withdrawn(Study closed due to ... More >>lack of recruitment) Less << March 2022 Denmark ... More >> Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00002569 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT00417014 Lymphoma Not Applicable Unknown - -
NCT00795613 HODGKIN LYMPHOMA Phase 2 Unknown October 2015 Israel ... More >> The Chaim Sheba Medical Center Tel Hashomer, Israel Italy Ospedale S. Gerardo Monza, Milano, Italy, 20052 A.O. Universitaria S. Luigi Gonzaga Orbassano, Torino, Italy, 10043 A.O. Universitaria Ospedali Riuniti Osp. Umberto I Ancona, Italy, 60100 Ospedali Riuniti Bergamo, Italy, 24128 Ospedale Generale Regionale Bolzano Bolzano, Italy, 39100 Ospedale Roberto Binaghi Cagliari, Italy, 09126 A.O. Universitaria Osp. Vittorio Emanuele E Ferrarotto Catania, Italy, 95124 Azienda Ospedaliera S. Croce E Carle Cuneo, Italy, 12100 Azienda Ospedaliera Universitaria S. Martino Genova, Italy, 16126 Ospedale S. Raffaele Turro Milano, Italy, 20127 Irccs - Istituto Nazionale Dei Tumori (Int) Milano, Italy, 20133 Irccs Istituto Nazionale Dei Tumori (Int) Milano, Italy, 20133 A.O. Universitaria Federico Ii Napoli, Italy, 80131 Azienda Ospedaliera Padova, Italy, 35127 Azienda Ospedaliera V. Cervello Palermo, Italy, 90146 Ospedale Silvestrini-S.Andrea Delle Fratte Perugia, Italy, 06156 Ospedale S. Carlo Potenza, Italy, 85100 A.O. Universitaria Policlinico Tor Vergata Roma, Italy, 00133 Azienda Ospedaliera San Camillo-Forlanini Roma, Italy, 00149 Ospedale Mauriziano Umberto I Torino, Italy, 10128 A.O. Universitaria S. Giovanni Battista-Molinette Torino, Italy, 10134 Ospedale Policlinico G.B. Rossi Verona, Italy, 37134 Ospedale Di Vicenza Vicenza, Italy, 36100 Less <<
NCT00049439 Lymphoma Phase 2 Completed - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 United States, Ohio Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Kenya University of Nairobi College of Health Sciences Nairobi, Kenya Uganda Uganda Cancer Institute Kampala, Uganda Less <<
NCT00594815 Lymphoma Not Applicable Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00594815 - Completed - -
NCT02444000 Anaplastic Gliomas With 1p/19q... More >> Codeletion Less << Phase 3 Recruiting June 2024 France ... More >> Groupe Hospitalier Pitié Salpetriere Recruiting Paris, France, 75013 Contact: Jean-Yves Delattre, MD, PhD    +33(0) 1 42 16 03 85    jean-yves.delattre@aphp.fr Less <<
NCT00887146 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Recruiting - -
NCT01775475 AIDS-related Diffuse Large Cel... More >>l Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma AIDS-related Diffuse Small Cleaved Cell Lymphoma AIDS-related Immunoblastic Large Cell Lymphoma AIDS-related Lymphoblastic Lymphoma AIDS-related Peripheral/Systemic Lymphoma AIDS-related Small Noncleaved Cell Lymphoma Stage III AIDS-related Lymphoma Stage IV AIDS-related Lymphoma Less << Phase 2 Active, not recruiting February 2021 Kenya ... More >> Moi Teaching and Referral Hospital Eldoret, Kenya, 4606-30100 Zimbabwe University of Zimbabwe College of Health Sciences Harare, Zimbabwe Less <<
NCT02333513 Recurrent High-grade Glioma Not Applicable Unknown December 2017 China, Beijing ... More >> Beijing Tiantan Hospital Not yet recruiting Beijing, Beijing, China, 100050 Contact: Nan Ji, Medical Doctor    +86 15210503095    neurochina@sohu.com    China, Hebei Hebei Yanda Hospital Not yet recruiting Sanhe, Hebei, China, 065200 Contact: Nan Ji, Medical Doctor    +86 15210503095    neurochina@sohu.com Less <<
NCT00335140 Lymphoma Phase 2 Terminated(slow accrual) - -
NCT00335140 - Terminated(slow accrual) - -
NCT00002806 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinical and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT00003114 Lymphoma Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00002840 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT00989352 Primary Non Hodgkin Lymphoma o... More >>f the Central Nervous System Less << Phase 2 Unknown September 2011 Germany ... More >> University Medical Center Freiburg, Dept. of Internal Medicine I - Hematology and Oncology Recruiting Freiburg, Germany, 79106 Contact: Gerald Illerhaus, PD Dr.    +497612703785    Gerald.Illerhaus@uniklinik-freiburg.de    Contact: Elvira Burger    +497612707378    elvira.burger@uniklinik-freiburg.de    Principal Investigator: Gerald Illerhaus, PD Dr. Less <<
NCT00005796 Bone Marrow Suppression ... More >> Brain and Central Nervous System Tumors Drug/Agent Toxicity by Tissue/Organ Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5265 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00151281 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT00003929 Lymphoma Phase 2 Withdrawn - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00151281 - Completed - -
NCT00004010 Lymphoma Phase 2 Completed - -
NCT00052455 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT03495960 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Not yet recruiting October 31, 2023 Italy ... More >> Bari IRCCS Istituto Tumori Bari, Italy Meldola, IRST - ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI Meldola, Italy Milano, IRCCS Ospedale San Raffaele Milan, Italy, 20132 Milano - Îstituto Besta Milan, Italy Milano Niguarda Milan, Italy Modena, Policlinico Universitario Modena, Italy Padova, Istituto Oncologico Veneto Padova, Italy Parma, Azienda Ospedaliera Parma, Italy Pescara, Presidio Ospedaliero UOS dipartimentale centro di diagnosi e terapia Linfomi Pescara, Italy Piacenza Piacenza, Italy Ravenna - Ospedale di Ravenna - IRST Ravenna, Italy Reggio Emilia - Arcispedale Santa Maria Nuova - IRCCS Reggio Emilia, Italy Roma - Ospedale S. Andrea Roma, Italy Roma - Unicampus-Bio Roma, Italy S. Giovanni Rotondo - Casa Sollievo della sofferenza San Giovanni Rotondo, Italy Siena - Azienda Ospedaliera Universitaria Senese Siena, Italy Terni - Ospedale di Terni Terni, Italy Torino neurooncologia - AOU CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO Torino, Italy Tricase - Ospedale "Card. G. Panico" Tricase, Italy Udine, Azienda Ospedaliera Universitaria Udine, Italy Switzerland Basel - Universitätsspital Recruiting Basel, Switzerland Contact: Benjamin kasenda, MD          Principal Investigator: Benjamin Kasenda          IOSI - Oncology Institute of Southern Switzerland Bellinzona, Switzerland, 6500 Bern - Inselspital Bern, Switzerland Lausanne - CHUV Lausanne, Switzerland St. Gallen - Kantonsspital Saint Gallen, Switzerland Less <<
NCT03576378 Hodgkin Lymphoma Phase 1 Phase 2 Active, not recruiting October 30, 2023 Spain ... More >> Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain Institut Català d'Oncologia, Hospital Duran i Reynals L'Hospitalet De Llobregat, Barcelona, Spain Hospital Costa del Sol Marbella, Málaga, Spain Hospital Clinic i Provincial de Barcelona Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital de Basurto Bilbao, Spain Hospital General Universitario Gregorio Marañon Madrid, Spain Hospital Universitario 12 de Octubre Madrid, Spain Hospital Universitario La Paz Madrid, Spain Hospital Son Llatzer Palma De Mallorca, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital Universitario Donostia - Arantzazu San Sebastián, Spain Hospital Universitario Marqués de Valdecilla Santander, Spain Hospital Universitario Virgen del Rocío Sevilla, Spain Hospital Universitario Miguel Servet Zaragoza, Spain Less <<
NCT00002463 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00079105 Lymphoma Phase 2 Completed - -
NCT00074191 Lymphoma Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00596154 CNS Lymphoma ... More >>CNS Brain Cancer Non-Hodgkin's Lymphoma Less << Phase 2 Active, not recruiting December 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01124240 Newly Diagnosed Non Methylated... More >> Glioblastoma Multiforme Grade 4 Less << Phase 2 Unknown January 2014 Australia, New South Wales ... More >> Royal North Shore Hospital Recruiting Sydney, New South Wales, Australia, 2065 Contact: Sally McCowatt, Rn    61299265049    smccowat@nsccahs.health.nsw.gov.au    Contact: Helen Wheeler, MBBS    61299267111    hrwheeler@optusnet.com.au    Principal Investigator: Helen Wheeler, MBBS Less <<
NCT00003293 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT00079092 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Illinois ... More >> CCOP - Central Illinois Decatur, Illinois, United States, 62526 United States, North Carolina CCOP - Southeast Cancer Control Consortium Goldsboro, North Carolina, United States, 27534-9479 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, South Carolina CCOP - Greenville Greenville, South Carolina, United States, 29615 CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 Less <<
NCT00004004 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3300 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 United States, Georgia Emory University Hospital - Atlanta Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1082 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 United States, Texas University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 Less <<
NCT01399372 Chemotherapeutic Agent Toxicit... More >>y Cognitive/Functional Effects Lymphoma Neurotoxicity Radiation Toxicity Less << Phase 2 Active, not recruiting September 2026 -
NCT00003564 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Withdrawn(Study withdrawn.) - -
NCT00503594 Lymphoma Phase 2 Unknown July 2012 France ... More >> Groupe hospitalier la Pitié Salpétrière Recruiting Paris, France, 75013 Contact: Antonio OMURO, MD,PhD    + 33(0) 1 42 16 41 60    antonio.omuro@psl.aphp.fr Less <<
NCT02800447 Advanced Hodgkin's Lymphoma Not Applicable Active, not recruiting December 2018 -
NCT01737346 Recurrent Glioblastoma Multifo... More >>rme Less << Phase 2 Unknown April 2014 Korea, Republic of ... More >> Ajou University Hospital Recruiting Wonchon-dong, Suwon, Korea, Republic of, 443-721 Contact: Se-Hyuk Kim, Doctor    82-31-219-5235    nsksh@ajou.ac.kr    Principal Investigator: Se-Hyuk Kim, Doctor Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.52mL

0.90mL

0.45mL

22.59mL

4.52mL

2.26mL

45.19mL

9.04mL

4.52mL

References

 

Historical Records

Categories